MMaT-3 policy decreases survival, increases recurrence after transplant in HCC patients

WASHINGTON — The MELD score at transplant minus three points policy led to poor survival and recurrence outcomes after liver transplantation among patients with hepatocellular carcinoma, according to research at The Liver Meeting.“Patients with HCC have been disadvantaged by the use of MELD score for prioritization for liver transplant,” Anjiya Shaikh, MD, an internal medicine resident at the University of Connecticut, told attendees. “As we all know, MELD score is a good predictor for 3-month mortality in chronic liver disease patients. However, it doesn’tRead More